Which companies discussed Share Buybacks in Health Care in earnings calls?

321 companies mentioned share buybacks across 712 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were Zomedica Corp. (10 calls), Exelixis, Inc. (10 calls), Qiagen N.V. (9 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning Share Buybacks
2024Q4110
2025Q1162
2025Q2107
2025Q3136
2025Q4148
2026Q1213
2026Q2182
2026Q3166
2026Q432

Companies ranked by mentions

Company Ticker Sector Calls Last mention
Zomedica Corp. ZOMDF Health Care 10 Oct 23, 2026
Exelixis, Inc. EXEL Health Care 10 Sep 9, 2026
Qiagen N.V. QGEN Health Care 9 Sep 14, 2026
Royalty Pharma plc RPRX Health Care 8 Sep 23, 2026
Zoetis Inc. ZTS Health Care 8 Aug 6, 2026
Novartis AG NOVN Health Care 7 Oct 27, 2026
Thermo Fisher Scientific Inc. TMO Health Care 7 Oct 21, 2026
Revvity, Inc. RVTY Health Care 7 Sep 14, 2026
Viatris Inc. VTRS Health Care 7 Aug 6, 2026
Zimmer Biomet Holdings, Inc. ZBH Health Care 7 Jun 8, 2026
ResMed Inc. RMD Health Care 6 Oct 29, 2026
Align Technology, Inc. ALGN Health Care 6 Oct 28, 2026
Universal Health Services, Inc. UHS Health Care 6 Oct 28, 2026
CVS Group plc CVSG Health Care 6 Oct 1, 2026
Zymeworks Inc. ZYME Health Care 6 Sep 28, 2026
GE HealthCare Technologies Inc. GEHC Health Care 6 Sep 9, 2026
Becton, Dickinson and Company BDX Health Care 6 Sep 9, 2026
Haemonetics Corporation HAE Health Care 6 Aug 6, 2026
Vertex Pharmaceuticals Incorporated VRTX Health Care 6 Jun 10, 2026
Roivant Sciences Ltd. ROIV Health Care 6 Jun 9, 2026
Regeneron Pharmaceuticals, Inc. REGN Health Care 5 Sep 23, 2026
Novo Nordisk A/S NOVOB Health Care 5 Sep 21, 2026
Halozyme Therapeutics, Inc. HALO Health Care 5 Sep 15, 2026
Charles River Laboratories International, Inc. CRL Health Care 5 Sep 14, 2026
The Cooper Companies, Inc. COO Health Care 5 Sep 9, 2026
UnitedHealth Group Incorporated UNH Health Care 5 Sep 9, 2026
Ambea AB (publ) AMBEA Health Care 5 Aug 19, 2026
Fresenius SE & Co. KGaA FRE Health Care 5 Aug 5, 2026
Fresenius Medical Care AG FME Health Care 5 Aug 4, 2026
Convatec Group PLC CTEC Health Care 5 Aug 4, 2026
Sanofi SAN Health Care 5 Jul 30, 2026
BridgeBio Pharma, Inc. BBIO Health Care 4 Oct 29, 2026
Stryker Corporation SYK Health Care 4 Oct 29, 2026
Baxter International Inc. BAX Health Care 4 Oct 29, 2026
CSL Limited CSL Health Care 4 Oct 26, 2026
Eurofins Scientific SE ERF Health Care 4 Oct 21, 2026
Physitrack PLC PTRK Health Care 4 Oct 20, 2026
Carasent AB (publ) CARA Health Care 4 Oct 15, 2026
Cronos Group Inc. CRON Health Care 4 Sep 24, 2026
Teva Pharmaceutical Industries Limited TEVA Health Care 4 Sep 22, 2026
Henry Schein, Inc. HSIC Health Care 4 Sep 15, 2026
IDEXX Laboratories, Inc. IDXX Health Care 4 Sep 14, 2026
Aspen Pharmacare Holdings Limited APN Health Care 4 Sep 3, 2026
Protagonist Therapeutics, Inc. PTGX Health Care 4 Aug 31, 2026
Bavarian Nordic A/S BAVA Health Care 4 Aug 21, 2026
ALK-Abelló A/S ALKB Health Care 4 Aug 20, 2026
Attendo AB (publ) ATT Health Care 4 Aug 20, 2026
Solana Company HSDT Health Care 4 Aug 14, 2026
Hyperion DeFi, Inc. HYPD Health Care 4 Aug 12, 2026
HLS Therapeutics Inc. HLS Health Care 4 Aug 12, 2026

Representative quotes

…benefit of Apnimeds. There's some non-op benefit in the earnings per share. We also had a much more weighted share buyback in the first quarter. So we talked about almost $1 billion worth of cash deployed towards share buyback. You saw our Wassa come down quite…
— ResMed Inc. (RMD), October 29, 2026. Read the full transcript →
…number of those launches will occur in '27. Vijay Kumar (Analysts): That's helpful. Maybe, Preston one for you. I saw the buyback in the quarter. You have a new authorization for $3 billion. What's the, I guess, philosophy behind capital allocation editions, right? Is this something…
— Stryker Corporation (SYK), October 29, 2026. Read the full transcript →
Finally, our strategic and financial posture continues to focus on taking advantage of our disconnect from intrinsic value through our previously discussed share buyback program and judicious use of resources to capture the full opportunity from each of our launches. With that, I'll turn it over…
— BridgeBio Pharma, Inc. (BBIO), October 29, 2026. Read the full transcript →
…million to $300 million in adjusted EBITDA. In the quarter, we repurchased just over 3 million shares of our stock, bringing our total buyback since August of 2025 to 10 million shares and our shares outstanding to 78 million, down from 87 million…
— Pediatrix Medical Group, Inc. (MD), October 29, 2026. Read the full transcript →

Frequently asked questions

What is Share Buybacks and why are companies discussing it?

Repurchase authorisations and execution — the capital-return signal investors track alongside dividends.

Which company mentioned share buybacks most in Health Care in the past year?

Zomedica Corp. (ZOMDF) led with 10 calls referencing share buybacks, most recently on October 23, 2026.

How can I track share buybacks mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Last updated: October 31, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (buyback, buyback, buybacks, share repurchase, share repurchases). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.